Funded Tech Companies
Chondrial Therapeutics
Researching who provided funding to Chondrial Therapeutics? Deerfield Capital, private investors and Indiana University Foundation joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Chondrial Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
150 Monument Rd. 207
Bala Cynwyd, PA 19004
USA
Bala Cynwyd, PA 19004
USA
Phone
Email Address
Company Background Information
Overview
Chondrial Therapeutics is an emerging biotechnology company focused on the treatment of rare mitochondrial diseases. Chondrial's lead compound is CTI-1601, which the Company is developing as a potential treatment for Friedreich's Ataxia.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/7/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carole Ben-Maimon
Chief Scientific Officer
Mark Payne
VP - Client Services
David Bettoun
VP - Operations
John Berman
VP - Regulatory Affairs
Jennifer Johansson
Company Investors
- Deerfield Capital (William Slattery)
- Indiana University Foundation
- Private Investors (Carole Ben-Maimon)
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs